Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.79 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.79 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.79 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.79 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.79 |
| ▸ | STAT3 | P40763 | 2/20 | 0.79 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.79 |
| ▸ | RELA | Q04206 | 2/20 | 0.79 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.77 |
| ▸ | CA12 | O43570 | 2/20 | 0.77 |
| ▸ | CA1 | P00915 | 2/20 | 0.77 |
| ▸ | CA2 | P00918 | 2/20 | 0.77 |
| ▸ | CA3 | P07451 | 2/20 | 0.77 |
| ▸ | PKM | P14618 | 2/20 | 0.77 |
| ▸ | CA4 | P22748 | 2/20 | 0.77 |
| ▸ | CA6 | P23280 | 2/20 | 0.77 |
| ▸ | CA5A | P35218 | 2/20 | 0.77 |
| ▸ | SNCA | P37840 | 2/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dehydrozingerone SCHEMBL30310276 | 1.00 | APP (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| Dehydrozingerone SCHEMBL498223 | 1.00 | APP (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| Dehydrozingerone SCHEMBL29691993 | 1.00 | APP (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| Dehydrozingerone SCHEMBL9104958 | 0.98 | APP (0.97) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| Dehydrozingerone SCHEMBL27764046 | 0.91 | APP (0.83) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| SCHEMBL29478095 | 0.88 | CYP2D6 (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| SCHEMBL1493283 | 0.88 | CYP2D6 (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| SCHEMBL1493282 | 0.88 | CYP2D6 (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| SCHEMBL30668505 | 0.88 | CYP2D6 (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| SCHEMBL9907021 | 0.88 | APP (0.78) | APPCYP2D6NFKB1CYP1A2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 769 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250327100-A1 | Strain of Pseudomonas Putida Genetically Modified to Express a Benzalacetone Reductase | BGENE GENETICS (FR) | 2025-10-23 | — | — | US | claimed |
| US-20250171750-A1 | Modified Polyketide Synthase Enzymes and Uses Thereof | BGENE GENETICS (FR) | 2025-05-29 | — | — | US | claimed |
| EP-4560015-A2 | MODIFIED POLYKETIDE SYNTHASE ENZYMES AND USES THEREOF | BGene Genetics (FR) | 2025-05-28 | — | — | EP | claimed |
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | claimed |
| CN-115011576-B | Aquilaria sinensis-derived III-type polyketide synthase AsPKS, and encoding gene and application thereof | 中国医学科学院药用植物研究所 | 2024-10-25 | — | — | CN | claimed |
| CN-115161300-B | Aquilaria sinensis-derived III-type polyketide synthase AsPKS, and encoding gene and application thereof | 中国医学科学院药用植物研究所 | 2024-08-23 | — | — | CN | claimed |
| CN-114990084-B | Aquilaria sinensis-derived III-type polyketide synthase AsPKS4, and encoding gene and application thereof | 中国医学科学院药用植物研究所 | 2024-08-23 | — | — | CN | claimed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-20240180852-A1 | TREATMENT FOR MALIGNANT PLEURAL EFFUSION IN HUMANS | SIGNPATH PHARMA, INC. | 2024-06-06 | — | — | US | claimed |
| EP-4370674-A1 | STRAIN OF PSEUDOMONAS PUTIDA GENETICALLY MODIFIED TO EXPRESS A BENZALACETONE REDUCTASE | BGene Genetics (FR) | 2024-05-22 | — | — | EP | claimed |
| US-6540997-B1 | Shelf-stable, virulent preparation containing Agrobacterium cells, an acidulant and a phenolic compound | SINNOTT ROBERT A (US) | 2003-04-01 | — | — | US | claimed |
| EP-1292268-A2 | AGENT FOR DYEING KERATIN CONTAINING FIBERS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-03-19 | — | — | EP | claimed |
| WO-2001097764-A2 | AGENT FOR DYEING KERATIN CONTAINING FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-27 | — | — | WO | claimed |
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| EP-0873743-A2 | Use of benzylidene-ketones for dyeing keratinous fibers | Henkel Kommanditgesellschaft auf Aktien (DE) | 1998-10-28 | — | — | EP | claimed |
| WO-1995018606-A9 | CURCUMIN, ANALOGUES OF CURCUMIN AND NOVEL USES THEREOF | — | 1997-05-22 | — | — | WO | claimed |
| EP-0738143-A1 | CURCUMIN, ANALOGUES OF CURCUMIN AND NOVEL USES THEREOF | RESEARCH DEVELOPMENT FOUNDATION (US) | 1996-10-23 | — | — | EP | claimed |
| WO-1995018606-A1 | CURCUMIN, ANALOGUES OF CURCUMIN AND NOVEL USES THEREOF | RESEARCH DEVELOPMENT FOUNDATION (US) | 1995-07-13 | — | — | WO | claimed |
| CN-1093079-A | Adrenergic blocking agents for beta-type cells derived from compounds of the guaiacol class and their dehydrogenated compounds | CHEN YINGJUN (CN) | 1994-10-05 | — | — | CN | claimed |
| US-4927805-A | Hydrolysis of curcumin | MALLINCKRODT, INC. (US) | 1990-05-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240180852-A1 | TREATMENT FOR MALIGNANT PLEURAL EFFUSION IN HUMANS | MTDH, PLEC, LPCAT3 | APP 3737/4885CYP2D6 3138/4885NFKB1 793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.